Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
Clinical trial NCT02354222 · COMPLETED
Trial details
- NCT number
- NCT02354222
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-02-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.